Stay updated on Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Sign up to get notified when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-11T03:57:22.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T23:01:11.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-02-17T19:13:04.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T16:16:57.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.5%
    Check dated 2025-02-03T11:21:33.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-01-27T05:21:49.000Z thumbnail image

Stay in the know with updates to Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.